90.38
price down icon0.25%   -0.7932
 
loading
Schlusskurs vom Vortag:
$91.17
Offen:
$91.44
24-Stunden-Volumen:
8,443
Relative Volume:
0.02
Marktkapitalisierung:
$6.48B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-173.59M
KGV:
-48.85
EPS:
-1.85
Netto-Cashflow:
$-130.44M
1W Leistung:
+0.84%
1M Leistung:
-10.11%
6M Leistung:
+30.42%
1J Leistung:
+51.57%
1-Tages-Spanne:
Value
$90.11
$91.71
1-Wochen-Bereich:
Value
$85.38
$92.26
52-Wochen-Spanne:
Value
$59.99
$113.51

Nuvalent Inc Stock (NUVL) Company Profile

Name
Firmenname
Nuvalent Inc
Name
Telefon
508-446-2272
Name
Adresse
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Name
Mitarbeiter
127
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
NUVL's Discussions on Twitter

Vergleichen Sie NUVL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
NUVL 90.32 6.48B 0 -173.59M -130.44M -1.85
VRTX 445.00 115.74B 10.63B -479.80M -1.35B 13.33
REGN 736.17 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 583.62 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 247.09 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.19 24.49B 3.30B -501.07M 1.03B 11.54

Nuvalent Inc Stock (NUVL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-02-28 Fortgesetzt Guggenheim Buy
2024-02-23 Eingeleitet Robert W. Baird Outperform
2023-09-27 Eingeleitet Stifel Buy
2023-08-08 Eingeleitet SVB Securities Market Perform
2023-07-24 Eingeleitet Guggenheim Buy
2023-01-18 Eingeleitet Wedbush Outperform
2022-06-24 Eingeleitet BMO Capital Markets Outperform
Alle ansehen

Nuvalent Inc Aktie (NUVL) Neueste Nachrichten

pulisher
Nov 20, 2024

Nuvalent CEO Porter sells shares worth $2.37 million By Investing.com - Investing.com Australia

Nov 20, 2024
pulisher
Nov 20, 2024

Nuvalent CEO Porter sells shares worth $2.37 million - Investing.com India

Nov 20, 2024
pulisher
Nov 20, 2024

Nuvalent, Inc. (NASDAQ:NUVL) Position Reduced by Victory Capital Management Inc. - MarketBeat

Nov 20, 2024
pulisher
Nov 19, 2024

First Turn Management LLC Acquires 106,838 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely - Simply Wall St

Nov 18, 2024
pulisher
Nov 15, 2024

FY2024 EPS Estimates for Nuvalent Reduced by Leerink Partnrs - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

What is Wedbush's Forecast for Nuvalent FY2024 Earnings? - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Perceptive Advisors LLC Expands Stake in Nuvalent Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Paradigm Biocapital Advisors LP Acquires Significant Stake in Nu - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

State of New Jersey Common Pension Fund D Makes New $2.41 Million Investment in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

How to Take Advantage of moves in (NUVL) - Stock Traders Daily

Nov 14, 2024
pulisher
Nov 13, 2024

Nuvalent (NASDAQ:NUVL) Announces Quarterly Earnings Results - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Nuvalent (NASDAQ:NUVL) Stock Price Expected to Rise, BMO Capital Markets Analyst Says - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Nuvalent Reports Q3 2024 Progress and Financials - TipRanks

Nov 13, 2024
pulisher
Nov 12, 2024

Nuvalent Highlights Corporate and Pipeline Achievements, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2024 Financial Results - The Malaysian Reserve

Nov 12, 2024
pulisher
Nov 12, 2024

Nuvalent Secures $1.2B Cash Runway Through 2028, Reports Strong Trial Progress | NUVL Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Nuvalent Inc. (NUVL) Quarterly 10-Q Report - Quartzy

Nov 12, 2024
pulisher
Nov 11, 2024

Crescent Biopharma Appoints Susan Moran, MD, MSCE, and Alexandra Balcom, MBA, CPA, to Board of Directors - The Malaysian Reserve

Nov 11, 2024
pulisher
Nov 07, 2024

Nuvalent Appoints Chief Scientific Officer - Contract Pharma

Nov 07, 2024
pulisher
Nov 05, 2024

AlphaCentric Advisors LLC Invests $716,000 in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Nuvalent CFO Alexandra Balcom sells $891,879 in stock By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 04, 2024

Nuvalent CFO Alexandra Balcom sells $891,879 in stock - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Nuvalent's chief development officer Noci Darlene sells $442,980 in shares - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Nuvalent's chief development officer Noci Darlene sells $442,980 in shares By Investing.com - Investing.com Australia

Nov 04, 2024
pulisher
Nov 04, 2024

Nuvalent, Inc. (NASDAQ:NUVL) CFO Alexandra Balcom Sells 10,000 Shares - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

abrdn plc Sells 40,233 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

(NUVL) Technical Data - Stock Traders Daily

Nov 03, 2024
pulisher
Nov 02, 2024

Nuvalent, Inc. (NASDAQ:NUVL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Nov 02, 2024
pulisher
Oct 30, 2024

Nuvalent to Present Updated Data for ROS1-Selective Inhibitor, Z - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

Oversold Conditions For Nuvalent (NUVL) - Nasdaq

Oct 30, 2024
pulisher
Oct 30, 2024

Nuvalent Announces Promotion of Henry Pelish, Ph.D. to Chief Sci - GuruFocus.com

Oct 30, 2024
pulisher
Oct 28, 2024

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update - StockTitan

Oct 28, 2024
pulisher
Oct 27, 2024

Nuvalent to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GuruFocus.com

Oct 27, 2024
pulisher
Oct 25, 2024

UBS Initiates Coverage of Nuvalent (NUVL) with Neutral Recommendation - MSN

Oct 25, 2024
pulisher
Oct 24, 2024

Nuvalent, Inc. (NASDAQ:NUVL) Director Sells $195,500,000.00 in Stock - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Nuvalent sees $195.5 million stock sale by Deerfield Management - Investing.com

Oct 24, 2024
pulisher
Oct 24, 2024

Nuvalent (NASDAQ:NUVL) Earns Neutral Rating from Analysts at UBS Group - MarketBeat

Oct 24, 2024
pulisher
Oct 23, 2024

Where are the Opportunities in (NUVL) - Stock Traders Daily

Oct 23, 2024
pulisher
Oct 23, 2024

Nuvalent (NASDAQ:NUVL) Shares Gap DownShould You Sell? - MarketBeat

Oct 23, 2024
pulisher
Oct 17, 2024

Nuvalent CEO Porter sells shares worth $2.76 million - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) CEO Sells 27,000 Shares of Stock - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

Nuvalent CEO Porter sells shares worth $2.76 million By Investing.com - Investing.com UK

Oct 17, 2024
pulisher
Oct 12, 2024

AQR Capital Management LLC Has $1.01 Million Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Oct 12, 2024
pulisher
Oct 12, 2024

AQR Capital Management LLC Sells 8,783 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat

Oct 12, 2024
pulisher
Oct 09, 2024

The Attractiveness of Investing In Nuvalent Inc (NUVL) is Growing - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Financial Metrics Unveiled: Nuvalent Inc (NUVL)’s Key Ratios in the Spotlight - The Dwinnex

Oct 09, 2024
pulisher
Oct 08, 2024

Nuvalent, Inc. (NASDAQ:NUVL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

NVL-655 overcomes ALK inhibitor limitations - BioWorld Online

Oct 08, 2024
pulisher
Oct 04, 2024

JPMorgan Chase & Co. Boosts Nuvalent (NASDAQ:NUVL) Price Target to $125.00 - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

Nuvalent executive sells over $500k in stock, buys $94.6k By Investing.com - Investing.com Australia

Oct 03, 2024
pulisher
Oct 03, 2024

Nuvalent, Inc. (NASDAQ:NUVL) Shares Acquired by Dimensional Fund Advisors LP - MarketBeat

Oct 03, 2024

Finanzdaten der Nuvalent Inc-Aktie (NUVL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Nuvalent Inc-Aktie (NUVL) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Porter James Richard
President and CEO
Nov 15 '24
Sale
87.94
27,000
2,374,479
188,113
Noci Darlene
Chief Development Officer
Nov 01 '24
Option Exercise
14.40
5,000
72,000
38,300
Noci Darlene
Chief Development Officer
Nov 01 '24
Sale
88.60
5,000
442,980
33,300
Balcom Alexandra
Chief Financial Officer
Oct 31 '24
Option Exercise
27.85
10,000
278,500
43,300
Balcom Alexandra
Chief Financial Officer
Oct 31 '24
Sale
89.19
10,000
891,879
33,300
Shair Matthew
Director
Oct 28 '24
Sale
91.73
2,000
183,468
224,522
Flynn James E
Director
Oct 22 '24
Sale
97.75
2,000,000
195,500,000
8,670,512
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):